Company page

Canopus Biopharma, Inc.

Canopus Biopharma, Inc. (Ticker: CBIA) is a public company operating in the American market, with a market capitalization of approximately $4.55 billion. The company focuses on biopharmaceuticals, aiming to develop innovative solutions in the healthcare sector. Investors can track its performance and market activities through its dedicated public company page on 6ix.